v3.26.1
Condensed Consolidated Statements of Stockholders' Equity and Mezzanine Equity (Unaudited) - USD ($)
shares in Thousands
Total
KSOP redeemable common stock conversion
Redeemable Common Stock
Redeemable Common Stock
KSOP redeemable common stock conversion
Total ADS Stockholders’ Equity
Common Stock
Paid-in Capital
Common Stock in Treasury
Accumulated Other Comprehensive Loss
Retained Earnings
Noncontrolling Interest in Subsidiaries
Beginning balance, common stock (in shares) at Mar. 31, 2025           83,750          
Beginning balance, treasury stock (in shares) at Mar. 31, 2025               11,886      
Beginning balance at Mar. 31, 2025 $ 1,543,136,000       $ 1,525,436,000 $ 11,694,000 $ 1,277,694,000 $ (1,219,408,000) $ (37,178,000) $ 1,492,634,000 $ 17,700,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 144,091,000       143,922,000         143,922,000 169,000
Other comprehensive loss 6,911,000       5,575,000       5,575,000   1,336,000
Common stock dividends (14,021,000)       (14,021,000)         (14,021,000)  
KSOP redeemable common stock conversion (in shares)           287          
KSOP redeemable common stock conversion 4,667,000       4,667,000 $ 3,000 4,664,000        
Exercise of common stock options (in shares)           10          
Exercise of common stock options 549,000       549,000 $ 0 549,000        
Restricted stock awards (in shares)           84   28      
Restricted stock awards (3,215,000)       (3,215,000) $ 1,000   $ (3,216,000)      
Performance-based restricted stock units (in shares)           83   28      
Stock-based compensation expense 8,404,000       8,404,000   8,404,000        
Stock-based compensation expense           $ 1,000          
ESPP Share Issuance (in shares)           33          
ESPP share issuance 3,236,000       3,236,000   3,235,000        
Performance-based restricted stock units (in shares) (3,466,000)       (3,466,000) $ 1,000   $ (3,467,000)      
Other (1,000)       (1,000)   (1,000)        
Ending balance, common stock (in shares) at Jun. 30, 2025           84,247          
Ending balance, treasury stock (in shares) at Jun. 30, 2025               11,942      
Ending balance at Jun. 30, 2025 1,690,291,000       1,671,086,000 $ 11,700,000 1,294,545,000 $ (1,226,091,000) (31,603,000) 1,622,535,000 19,205,000
Mezzanine equity, beginning balance (in shares) at Mar. 31, 2025     5,702                
Mezzanine equity, beginning balance at Mar. 31, 2025 92,652,000   $ 92,652,000                
Increase (Decrease) in Temporary Equity [Roll Forward]                      
KSOP redeemable common stock conversion (in shares)       (287)              
KSOP redeemable common stock conversion   $ (4,667,000)   $ (4,667,000)              
Mezzanine equity, ending balance (in shares) at Jun. 30, 2025     5,415                
Mezzanine equity, ending balance at Jun. 30, 2025 $ 87,985,000   $ 87,985,000                
Increase (Decrease) in Temporary Equity [Roll Forward]                      
Common stock dividends per share (in dollars per share) $ 0.18                    
Beginning balance, common stock (in shares) at Mar. 31, 2026 72,654         85,319          
Beginning balance, treasury stock (in shares) at Mar. 31, 2026               12,665      
Beginning balance at Mar. 31, 2026 $ 1,882,312,000       1,858,734,000 $ 11,710,000 1,342,091,000 $ (1,325,713,000) (32,290,000) 1,862,936,000 23,578,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 170,915,000       168,521,000         168,521,000 2,394,000
Other comprehensive loss (89,000)       (819,000)       (819,000)   730,000
Common stock dividends $ (15,348,000)       (15,348,000)         (15,348,000)  
Share repurchases (in shares) 1,600             1,638      
Stock Repurchased During Period, Value $ 228,491,000       228,491,000     $ (228,491,000)      
KSOP redeemable common stock conversion (in shares)           111          
KSOP redeemable common stock conversion 1,804,000       1,804,000 $ 1,000 1,803,000        
Exercise of common stock options (in shares)           5          
Exercise of common stock options 475,000       475,000 $ 0 475,000        
Restricted stock awards (in shares)           85   28      
Restricted stock awards (3,735,000)       (3,735,000) $ 1,000   $ (3,736,000)      
Performance-based restricted stock units (in shares)           150   51      
Stock-based compensation expense 13,274,000       13,274,000   13,274,000        
Stock-based compensation expense           $ 1,000          
ESPP Share Issuance (in shares)           32          
ESPP share issuance 4,272,000       4,272,000   4,271,000        
Performance-based restricted stock units (in shares) (6,991,000)       (6,991,000) $ 1,000   $ (6,992,000)      
Other $ (3,000)       (3,000)   (3,000)        
Ending balance, common stock (in shares) at Jun. 30, 2026 71,320         85,702          
Ending balance, treasury stock (in shares) at Jun. 30, 2026               14,382      
Ending balance at Jun. 30, 2026 $ 1,818,395,000       $ 1,791,693,000 $ 11,714,000 $ 1,361,911,000 $ (1,564,932,000) $ (33,109,000) $ 2,016,109,000 $ 26,702,000
Mezzanine equity, beginning balance (in shares) at Mar. 31, 2026     4,533                
Mezzanine equity, beginning balance at Mar. 31, 2026 73,652,000   $ 73,652,000                
Increase (Decrease) in Temporary Equity [Roll Forward]                      
KSOP redeemable common stock conversion (in shares)       (111)              
KSOP redeemable common stock conversion   $ (1,804,000)   $ (1,804,000)              
Mezzanine equity, ending balance (in shares) at Jun. 30, 2026     4,422                
Mezzanine equity, ending balance at Jun. 30, 2026 $ 71,848,000   $ 71,848,000                
Increase (Decrease) in Temporary Equity [Roll Forward]                      
Common stock dividends per share (in dollars per share) $ 0.20